Singapore markets open in 28 minutes

Straits Times Index
3,296.89
+4.20(+0.13%)
S&P 500
5,064.20
+45.81(+0.91%)
Dow
38,225.66
+322.37(+0.85%)
Nasdaq
15,840.96
+235.48(+1.51%)
Bitcoin USD
58,907.64
+830.81(+1.43%)
CMC Crypto 200
1,273.24
+2.49(+0.20%)

ABT May 2024 104.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.3400

-1.7300

(-56.35%)

As of 12:25PM EDT. Market open.

Zacks
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Zacks
PBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR Newswire
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.